Botanix Pharmaceuticals Ltd (BOT) — Long-term Investment Intensity
Botanix Pharmaceuticals Ltd (BOT) has a Long-term Investment Intensity of 0.4% as of June 2022. Long-term investments of AU$61.71K represent 0.4% of total assets of AU$14.04 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Botanix Pharmaceuticals Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Botanix Pharmaceuticals Ltd Long-term Investment Intensity (2020–2022)
This chart shows how Botanix Pharmaceuticals Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2020 to 2022. As of June 2022, the intensity stands at 0.4%, reflecting long-term investments of AU$61.71K against total assets of AU$14.04 Million AUD. Explore how well can Botanix Pharmaceuticals Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Botanix Pharmaceuticals Ltd (2020–2022)
The table below presents the year-by-year Long-term Investment Intensity for Botanix Pharmaceuticals Ltd from 2020 to 2022, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Botanix Pharmaceuticals Ltd (BOT) market capitalisation.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 0.4% | AU$61.71K | AU$14.04 Million | ▲ +0.2 pp |
| 2021 | 0.3% | AU$62.37K | AU$21.95 Million | ▼ -0.1 pp |
| 2020 | 0.4% | AU$88.73K | AU$25.31 Million | — |